Cathy A. Payne

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes

Christopher G. Duncan, Patrick Killela, Cathy A. Payne et al. · Oncotarget · 2010 · 117 citations · Full text

IQGAP1 and IGFBP2

Kerrie L. McDonald, Maree G. O’Sullivan, Jonathon Parkinson et al. · Journal of Neuropathology & Experimental Neurology · 2007 · 92 citations · Full text

World Health Organization, Grade Iii Gliomas, Genetics +17

Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma

Cathy A. Payne, Sanaz Maleki, Marinella Messina et al. · Molecular Cancer Therapeutics · 2008 · 27 citations · Full text

The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20years’ experience at a single centre

Jonathon Parkinson, Vahid Afaghi, Cathy A. Payne et al. · Journal of Clinical Neuroscience · 2011 · 15 citations

Pediatric Brain Tumors, Clinical Factors, Medicine +11

HDMX regulates p53 activity and confers chemoresistance to 3-Bis(2-chloroethyl)-1-nitrosourea

Genglin Jin, Stephen Cook, Bo Cui et al. · Neuro-Oncology · 2010 · 14 citations · Full text

Neuro-oncology, Glioma, Tumor Heterogeneity +15